Dudediligence.

Aura Biosciences, Inc

AURANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$21.0MSep ’24−$25.8MDec ’24−$27.5MMar ’25−$27.0MJun ’25−$26.1MSep ’25−$25.6MDec ’25−$33.7MMar ’26−$45.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$35.3M−$60.3M−$85.0M−$96.1M−$112.8M
Net income−$35.3M−$58.8M−$76.4M−$86.9M−$106.2M
Operating cash flow−$32.4M−$54.6M−$63.8M−$79.8M−$84.7M
Free cash flow−$34.5M−$55.7M−$64.6M−$81.1M−$85.2M
Cash$149.1M$121.6M$41.1M$31.7M$59.5M
Shares outstanding29.2M37.8M49.4M50.0M63.6M